The company expands its production capacity for clinical-grade xenokidneys and xenohearts in Texas.
Live Poll
Do you support the use of lab-grown animal organs to address the human organ transplant shortage?
October 13, 2026
Houston Biotech Secured $120 Million for ImplantsDuracyte has raised funds to develop subcutaneous engineered cell implants that secrete biologics.
October 13, 2026
Oorja Bio Initiated Phase 2 Clinical TrialThe company began the first patient screening for its study on the idiopathic pulmonary fibrosis drug ORJ-001.
October 2, 2026
Rice University Researchers Created Living Pharmacy ImplantThe new implantable device utilizes engineered protein producers to continuously deliver vital biologic medications.
October 1, 2026
CTMC Began Pivotal TIL Manufacturing in HoustonThe Houston-based company has launched a partner program for tumor-infiltrating lymphocyte therapy production.
September 30, 2026
Baylor Researchers Identified VAV1 Degrader CompoundsThe study reveals new molecular glue compounds capable of degrading the VAV1 protein implicated in disease.
September 22, 2026
Eos SENOLYTIX Announced Keynote for Mitochondria CongressThe Houston-based biotech firm prepares for a major industry presentation ahead of its upcoming merger vote.
